1. FRI0377 Fc-Gamma Receptor Polymorphisms Differentially Influence Susceptibility to Systemic Lupus Erythematosus and Disease-Related Manifestations. (9th June 2015) Authors: Tsang-A-Sjoe, M. W.-P.; Nagelkerke, S.Q.; Bultink, I.E.; Geissler, J.; Tanck, M.W.; Tacke, C.E.; Ellis, J.E.; Zenz, W.; Bijl, M.; Berden, J.H.; de Leeuw, K.; Derksen, R.H.; Kuipers, T.W.; Voskuyl, A.E. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 563 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SAT0201 Induction therapy with short-term high dose intravenous cyclophosphamide followed by mycophenolate mofetil in patients with proliferative lupus nephritis. (23rd January 2014) Authors: Arends, S.; Berden, J.H.; Grootscholten, C.; Derksen, R.H.; Berger, S.P.; de Sévaux, R.G.; Voskuyl, A.E.; Bijl, M. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 540 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗